ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.

Boaz Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.